Cargando…
Effects of Cannabidiol on Innate Immunity: Experimental Evidence and Clinical Relevance
Cannabidiol (CBD) is the main non-psychotropic cannabinoid derived from cannabis (Cannabis sativa L., fam. Cannabaceae). CBD has received approval by the Food and Drug Administration (FDA) and European Medicines Agency (EMA) for the treatment of seizures associated with Lennox–Gastaut syndrome or Dr...
Autores principales: | Martini, Stefano, Gemma, Alessandra, Ferrari, Marco, Cosentino, Marco, Marino, Franca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9964491/ https://www.ncbi.nlm.nih.gov/pubmed/36834537 http://dx.doi.org/10.3390/ijms24043125 |
Ejemplares similares
-
Immunomodulatory Potential of Cannabidiol in Multiple Sclerosis: a Systematic Review
por: Furgiuele, Alessia, et al.
Publicado: (2021) -
Effect of Cannabidiol on Human Peripheral Blood Mononuclear Cells and CD4+ T Cells
por: Furgiuele, Alessia, et al.
Publicado: (2023) -
A Novel Standardized Cannabis sativa L. Extract and Its Constituent Cannabidiol Inhibit Human Polymorphonuclear Leukocyte Functions
por: Mabou Tagne, Alex, et al.
Publicado: (2019) -
Polymorphisms of Dopamine Receptor Genes and Parkinson’s Disease: Clinical Relevance and Future Perspectives
por: Magistrelli, Luca, et al.
Publicado: (2021) -
Dopaminergic regulation of inflammation and immunity in Parkinson's disease: friend or foe?
por: Furgiuele, Alessia, et al.
Publicado: (2023)